Sponsored Links
BRIEF-Keryx Biopharmaceuticals jumps in premarket after kidney disease drug meets trial goal
NEW YORK |
NEW YORK Jan 28 (Reuters) - Keryx Biopharmaceuticals Inc : * Keryx Biopharma jumps 46.4 percent to $5.02 in premarket after kidney disease drug meets late-stage trial goal
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters